PL342311A1 - Novel derivatives of carboxylic acids containing pyrimidinic rings substituted at position 5, method of obtaining them and application of such derivatives - Google Patents
Novel derivatives of carboxylic acids containing pyrimidinic rings substituted at position 5, method of obtaining them and application of such derivativesInfo
- Publication number
- PL342311A1 PL342311A1 PL99342311A PL34231199A PL342311A1 PL 342311 A1 PL342311 A1 PL 342311A1 PL 99342311 A PL99342311 A PL 99342311A PL 34231199 A PL34231199 A PL 34231199A PL 342311 A1 PL342311 A1 PL 342311A1
- Authority
- PL
- Poland
- Prior art keywords
- derivatives
- pyrimidinic
- obtaining
- application
- carboxylic acids
- Prior art date
Links
- 150000001735 carboxylic acids Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/60—Three or more oxygen or sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19806438A DE19806438A1 (de) | 1998-02-17 | 1998-02-17 | Neue Carbonsäurederivate mit 5-substituiertem Pyrimidinring, ihre Herstellung und Verwendung |
| PCT/EP1999/000776 WO1999042453A1 (de) | 1998-02-17 | 1999-02-05 | 5-substituierte pyrimidin-2-yloxy-carbonsäurederivate, deren herstellung und deren verwendung als endothelin-antagonisten |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL342311A1 true PL342311A1 (en) | 2001-06-04 |
Family
ID=7857948
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL99342311A PL342311A1 (en) | 1998-02-17 | 1999-02-05 | Novel derivatives of carboxylic acids containing pyrimidinic rings substituted at position 5, method of obtaining them and application of such derivatives |
Country Status (20)
| Country | Link |
|---|---|
| EP (1) | EP1066268A1 (no) |
| JP (1) | JP2002503726A (no) |
| KR (1) | KR20010086247A (no) |
| CN (1) | CN1291190A (no) |
| AR (1) | AR014960A1 (no) |
| AU (1) | AU3027199A (no) |
| BG (1) | BG104577A (no) |
| BR (1) | BR9907911A (no) |
| CA (1) | CA2321182A1 (no) |
| DE (1) | DE19806438A1 (no) |
| HR (1) | HRP20000602A2 (no) |
| HU (1) | HUP0100957A3 (no) |
| IL (1) | IL137038A0 (no) |
| NO (1) | NO20004075D0 (no) |
| PL (1) | PL342311A1 (no) |
| SK (1) | SK11512000A3 (no) |
| TR (1) | TR200002376T2 (no) |
| TW (1) | TW579376B (no) |
| WO (1) | WO1999042453A1 (no) |
| ZA (1) | ZA991214B (no) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19924892A1 (de) * | 1999-06-01 | 2000-12-07 | Basf Ag | Neue Carbonsäurederivate mit arylsubstituierten Stickstoffheterocyclen, ihre Herstellung und Verwendung als Endothelin Rezeptorantagonisten |
| US8168616B1 (en) * | 2000-11-17 | 2012-05-01 | Novartis Ag | Combination comprising a renin inhibitor and an angiotensin receptor inhibitor for hypertension |
| JP2010535210A (ja) | 2007-07-31 | 2010-11-18 | ギリード・コロラド・インコーポレーテッド | アンブリセンタンの代謝産物および誘導体 |
| ES2549379T3 (es) | 2008-01-22 | 2015-10-27 | Dow Agrosciences Llc | Derivados de 4-amino5-fluoropirimidina como fungicidas |
| PL2317851T3 (pl) * | 2008-08-01 | 2014-06-30 | Dow Agrosciences Llc | Zastosowanie 5-fluorocytozyny jako fungicydu |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4411225A1 (de) * | 1994-03-31 | 1995-10-05 | Basf Ag | Verwendung von Carbonsäurederivaten als Arzneimittel |
| DE19533023B4 (de) * | 1994-10-14 | 2007-05-16 | Basf Ag | Neue Carbonsäurederivate, ihre Herstellung und Verwendung |
| DE19614533A1 (de) * | 1996-04-12 | 1997-10-16 | Basf Ag | Neue alpha-Hydroxysäurederivate, ihre Herstellung und Verwendung |
| DE19614534A1 (de) * | 1996-04-12 | 1997-10-16 | Basf Ag | Neue Carbonsäurederivate, ihre Herstellung und Verwendung |
| ID26234A (id) * | 1996-12-18 | 2000-12-07 | Basf Ag | Turunan-turunan asam karboksilat heterosiklik, pembuatan dan penggunaannya sebagai antagonis-antagonis reseptor endotelen |
| DE19726146A1 (de) * | 1997-06-19 | 1998-12-24 | Basf Ag | Neue ß-Amino und ß-Azidopcarbonsäurederivate, ihre Herstellung und Verwendung als Endothelinrezeptorantagonisten |
| JP2001521927A (ja) * | 1997-10-31 | 2001-11-13 | ビーエーエスエフ アクチェンゲゼルシャフト | アミド側鎖を有する新規のカルボン酸誘導体、その製造およびエンドセリン受容体アンタゴニストとしての使用 |
-
1998
- 1998-02-17 DE DE19806438A patent/DE19806438A1/de not_active Withdrawn
-
1999
- 1999-02-05 TR TR2000/02376T patent/TR200002376T2/xx unknown
- 1999-02-05 IL IL13703899A patent/IL137038A0/xx unknown
- 1999-02-05 AU AU30271/99A patent/AU3027199A/en not_active Abandoned
- 1999-02-05 JP JP2000532405A patent/JP2002503726A/ja active Pending
- 1999-02-05 WO PCT/EP1999/000776 patent/WO1999042453A1/de not_active Ceased
- 1999-02-05 CN CN99803037A patent/CN1291190A/zh active Pending
- 1999-02-05 CA CA002321182A patent/CA2321182A1/en not_active Abandoned
- 1999-02-05 KR KR1020007008925A patent/KR20010086247A/ko not_active Withdrawn
- 1999-02-05 SK SK1151-2000A patent/SK11512000A3/sk unknown
- 1999-02-05 PL PL99342311A patent/PL342311A1/xx unknown
- 1999-02-05 BR BR9907911-9A patent/BR9907911A/pt not_active IP Right Cessation
- 1999-02-05 HR HR20000602A patent/HRP20000602A2/hr not_active Application Discontinuation
- 1999-02-05 HU HU0100957A patent/HUP0100957A3/hu unknown
- 1999-02-05 EP EP99911657A patent/EP1066268A1/de not_active Withdrawn
- 1999-02-10 TW TW088102031A patent/TW579376B/zh active
- 1999-02-16 ZA ZA9901214A patent/ZA991214B/xx unknown
- 1999-02-16 AR ARP990100634A patent/AR014960A1/es not_active Application Discontinuation
-
2000
- 2000-07-04 BG BG104577A patent/BG104577A/bg unknown
- 2000-08-15 NO NO20004075A patent/NO20004075D0/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| BG104577A (bg) | 2001-03-30 |
| SK11512000A3 (sk) | 2001-04-09 |
| IL137038A0 (en) | 2001-06-14 |
| KR20010086247A (ko) | 2001-09-10 |
| NO20004075L (no) | 2000-08-15 |
| CN1291190A (zh) | 2001-04-11 |
| CA2321182A1 (en) | 1999-08-26 |
| HUP0100957A2 (hu) | 2002-02-28 |
| NO20004075D0 (no) | 2000-08-15 |
| EP1066268A1 (de) | 2001-01-10 |
| HRP20000602A2 (en) | 2001-06-30 |
| ZA991214B (en) | 2000-08-16 |
| WO1999042453A1 (de) | 1999-08-26 |
| HUP0100957A3 (en) | 2002-03-28 |
| TR200002376T2 (tr) | 2000-12-21 |
| DE19806438A1 (de) | 1999-08-19 |
| AU3027199A (en) | 1999-09-06 |
| JP2002503726A (ja) | 2002-02-05 |
| TW579376B (en) | 2004-03-11 |
| BR9907911A (pt) | 2000-10-24 |
| AR014960A1 (es) | 2001-04-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA9710038B (en) | Method for the production of levulinic acid and its derivatives | |
| PL325155A1 (en) | Method of obtaining l-amino acids | |
| PL332720A1 (en) | Novel derivatives of piperydinketone carboxylic acids, their production and application | |
| PL330753A1 (en) | Method of obtaining 2,3-dihalogenopropanols | |
| PL340034A1 (en) | Derivatives of tetrahydropyridopyrimidinone substituted at position 3, method of obtaining them and method of applying them | |
| PL329238A1 (en) | Novel derivatives of alpha-hydroxycarboxylic acids, their production and application | |
| PL319270A1 (en) | Novel derivative of 2,3-dibenzodiazepin, method of obtaining them and pharmaceutic composition | |
| PL329240A1 (en) | Novel derivatives of carboxylic acid, their production and application | |
| PL339759A1 (en) | Method of obtaining substituted 4-phenyl-4-cyanohexanic acids | |
| PL324588A1 (en) | Novel compounds-substituted piperydinodiones-2,6, method of obtaining them and drug containing such compounds | |
| PL322279A1 (en) | Method of obtaining 1,2-benzoylthiazolin-3-ones | |
| PL323388A1 (en) | Method of obtaining derivatives of carboxylic acids | |
| PL340033A1 (en) | Derivatives of 1,2-benzoisothiazole substituted at position 2, method of obtaining them and method of applying them | |
| PL335031A1 (en) | Compound and method of obtaining substituted 4-phenyl-4-cyanocyclohexanic acids | |
| PL330281A1 (en) | Method of obtaining derivatives of phenoxypropinic acid | |
| PL325398A1 (en) | Novel derivatives of carboxylic acids, their production and application | |
| PL319070A1 (en) | Derivatives of 1,25-dihydroxy-16,22,23-trisdehyrochoecalcifero, method of obtaining them and compositions containing such derivatives | |
| PL330406A1 (en) | Method of hydrocarboxylating pentenic acids | |
| PL302364A1 (en) | Method of carrying on hydrocarboxylation of lactones | |
| HUP9700877A3 (en) | Process for the preparation of arylamides of heteroaromatic carboxylic acids and one intermediate thereof | |
| PL336664A1 (en) | Method of obtaining 1,1,1,3,3- pentachlorobutane | |
| PL326699A1 (en) | Method of obtaining derivatives of 3-phenyl-1-methylenedioxyphenyl-indane 2-carboxylic acids | |
| PL315675A1 (en) | Derivatives of 12, 13-epoxytholosine and method of obtaining them | |
| SI0726270T1 (en) | Derivatives of 1,6-naphthyridone carboxylic acids | |
| PL314765A1 (en) | Microbiological method of obtaining heteroaromatic carboxylic acids |